Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Robotics Innovation Platform Technologies

Meet Carina, China’s Answer To Its Need For Modular Surgical Robotics

  • Interviews

Executive Summary

Since its founding in 2019, Ronovo Surgical has designed and built a modular surgical robot that could rival the likes of Medtronic’s Hugo and CMR Surgical’s Versius.

You may also be interested in...



CMR Signs Deal With J&J To Bring Robots To Europe And South America

CMR Surgical will collaborate with Johnson & Johnson/Ethicon to expand access to its Versius robotic surgery system.

Getting Out Of A Jam: Titan Medical Pulls Itself From The Brink With Medtronic Deal

Titan Medical has met all the milestones of partnership with Medtronic and is continuing to develop its Enos single-port robotic system.

CMR Surgical Closes SoftBank-Led Funding Round Worth $600M

CMR Surgical has raised $600m to globally commercialize its Versius surgical robotics platform.

Table

View full table

Topics

Related Companies

Tags:
Robotics Innovation Platform Technologies
Latest Headlines

MDR Amending Regulation Officially Published And Already In Force

EU MDR Notified Bodies Reach 38 After Another Designation

Medtronic Earns CE Mark For Affera Ablation System, Touts New PFA Results

News We’re Watching – FDA Mammography Update, SVB Collapse, Zoll's Data Breach, And More

See All
UsernamePublicRestriction

Register

MT147693

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By